Venture Visionary Partners’s Insmed INSM Stock Holding History

Venture Visionary Partners’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,400	Closed	-$202K	–	681
2025 Q3	$202K	Buy	+1,400	New	+$172K	0.01%	590

Other funds holding INSM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Venture Visionary Partners's INSM Position: Q4 2025 in Review

Venture Visionary Partners sold out of Insmed (INSM) in Q4 2025, closing a stake of 1,400 shares — an estimated $202K sold.

Venture Visionary Partners first reported a position in INSM in Q3 2025 and held it in 1 quarter. The position peaked at $202K in Q3 2025. 678 funds tracked by Wall St. Rank hold INSM as of Q4 2025.

Venture Visionary Partners reported no remaining Insmed position as of Q4 2025 after selling out during the quarter.
Venture Visionary Partners sold 1,400 Insmed shares in Q4 2025, an estimated $202K.
Venture Visionary Partners first reported a position in Insmed in Q3 2025 and held it in 1 quarter.
Venture Visionary Partners's Insmed position peaked at $202K in Q3 2025.
678 funds tracked by Wall St. Rank held Insmed as of Q4 2025.

Based on Venture Visionary Partners's 13F filing for Q4 2025, filed 13 Feb 2026.